Thursday, April 03 2025 | 04:45:23 AM

Matribhumi Samachar English

Breaking News

Datadog Unveils Plans for Data Center in Australia
Sixty North Gold Announces Closing of Second and Final Tranche of Non-Brokered Unit Offering
Eguana Announces Effective Date of Consolidation
Pine Cliff Energy Ltd. Provides 2025 Capex Guidance and Declares April Dividend
Searchlight Innovations Announces Amendment of Merger Agreement with Riverboat Energy
Sweet Poison Completes Name Change to Hyper Bit Technologies Ltd.
STLLR Gold Strengthens Leadership with Vice President of Finance Appointment
Dolly Varden Silver Announces Application to List on the NYSE American and Share Consolidation
Gold Digger Resources Engages Canadian Investor Relations Firm Investor Cubed
Immix and AITX’s Robotic Assistance Devices (RAD) Announce Plans to Develop Strategic Integration to Advance Real-Time Incident Management with AI-Driven Automation

Home / Tag Archives: Awakn Life Sciences

Tag Archives: Awakn Life Sciences

Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc

February 27, 2025 International

Toronto, Ontario–(Newsfile Corp. – February 27, 2025) – Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, is pleased to announce that, further to its press release of December 16, 2024, …

Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD

January 27, 2025 International

Toronto, Ontario–(Newsfile Corp. – January 27, 2025) – Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics for substance use and mental health disorders, is pleased to provide an update on its research and development (R&D) …